CRA’s Walter Colasante, Pascale Diesel, and Lev Gerlovin recently published a series of three articles in Cell & Gene on emerging gene and cell therapies and their impact on the market. Read the full series below.
How are cell and gene therapies changing drug development models?
New approaches to market access and reimbursement for gene and cell therapies
Four emerging commercialization strategies for gene and cell therapies
Review: Clinical Considerations & Payer Perspectives
Late October saw the annual gathering of oncologists and industry in Madrid for ESMO 2023, bringing with it a wave of new clinical results across cancers and a...